Literature DB >> 20181948

Unraveling the specificity of heparanase utilizing synthetic substrates.

Sherket B Peterson1, Jian Liu.   

Abstract

Heparanase is a promising anticancer target because of its involvement in cancer invasion and metastasis. Heparanase cleaves heparan sulfate (HS), a sulfated polysaccharide, and activates a series of HS-mediated cell proliferation and angiogenesis processes. Understanding the substrate specificity of heparanase will aid the discovery of heparanase inhibitors. Here, we sought to determine the specificity of heparanase using synthetic polysaccharide substrates. The substrates were prepared using purified HS biosynthetic enzymes. Using these substrates, we were able to dissect the structural moieties required for heparanase. Our data suggest that heparanase cleaves the linkage between a GlcA unit and an N-sulfo glucosamine unit carrying either a 3-O-sulfo or a 6-O-sulfo group. In addition, heparanase cleaves the linkage of a GlcA unit and N-sulfo glucosamine unit with a 2-O-sulfated GlcA residue, not a 2-O-sulfated IdoA residue, in proximity. We also discovered that the polysaccharide with repeating disaccharide units of IdoA2S-GlcNS inhibits the activity of heparanase. Our findings advance the understanding of the substrate specificity of heparanase and identify a lead compound for developing polysaccharide-based heparanase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20181948      PMCID: PMC2863188          DOI: 10.1074/jbc.M110.104166

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  Heparanase, a potential regulator of cell-matrix interactions.

Authors:  L A Dempsey; G J Brunn; J L Platt
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

2.  Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase.

Authors:  J Liu; N W Shworak; L M Fritze; J M Edelberg; R D Rosenberg
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

3.  Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.

Authors:  Ilana Doweck; Victoria Kaplan-Cohen; Inna Naroditsky; Edmond Sabo; Neta Ilan; Israel Vlodavsky
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

4.  Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis.

Authors:  M D Hulett; C Freeman; B J Hamdorf; R T Baker; M J Harris; C R Parish
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

Review 5.  Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.

Authors:  Neta Ilan; Michael Elkin; Israel Vlodavsky
Journal:  Int J Biochem Cell Biol       Date:  2006-07-06       Impact factor: 5.085

Review 6.  Heparanase as a molecular target of cancer chemotherapy.

Authors:  Siro Simizu; Keisuke Ishida; Hiroyuki Osada
Journal:  Cancer Sci       Date:  2004-07       Impact factor: 6.716

Review 7.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

8.  Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures.

Authors:  Jinghua Chen; Courtney L Jones; Jian Liu
Journal:  Chem Biol       Date:  2007-09

9.  Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

Authors:  M Bar-Ner; A Eldor; L Wasserman; Y Matzner; I R Cohen; Z Fuks; I Vlodavsky
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

10.  Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence.

Authors:  Yukihiko Okada; Shuhei Yamada; Minako Toyoshima; Jian Dong; Motowo Nakajima; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2002-09-03       Impact factor: 5.157

View more
  27 in total

1.  Heparanase affects secretory granule homeostasis of murine mast cells through degrading heparin.

Authors:  Bo Wang; Juan Jia; Xiao Zhang; Eyal Zcharia; Israel Vlodavsky; Gunnar Pejler; Jin-Ping Li
Journal:  J Allergy Clin Immunol       Date:  2011-05-14       Impact factor: 10.793

Review 2.  Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications.

Authors:  Biagio Ricciuti; Jennifer Foglietta; Rita Chiari; Amirhossein Sahebkar; Maciej Banach; Vanessa Bianconi; Matteo Pirro
Journal:  Med Oncol       Date:  2017-12-04       Impact factor: 3.064

3.  Involvement of Ext1 and heparanase in migration of mouse FBJ osteosarcoma cells.

Authors:  Yinan Wang; XiaoYan Yang; Sadako Yamagata; Tatsuya Yamagata; Toshinori Sato
Journal:  Mol Cell Biochem       Date:  2012-10-10       Impact factor: 3.396

4.  Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.

Authors:  Yanlei Yu; Asher Williams; Xing Zhang; Li Fu; Ke Xia; Yongmei Xu; Fuming Zhang; Jian Liu; Mattheos Koffas; Robert J Linhardt
Journal:  Glycobiology       Date:  2019-07-19       Impact factor: 4.313

5.  A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.

Authors:  Yang Mao; Yu Huang; Jo Ann Buczek-Thomas; Cheryl M Ethen; Matthew A Nugent; Zhengliang L Wu; Joseph Zaia
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

6.  Deciphering mode of action of heparanase using structurally defined oligosaccharides.

Authors:  Sherket Peterson; Jian Liu
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

7.  Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.

Authors:  Timothy R O'Leary; Yongmei Xu; Jian Liu
Journal:  Glycobiology       Date:  2012-09-26       Impact factor: 4.313

8.  Beta-Glucuronidase Catalyzes Deconjugation and Activation of Curcumin-Glucuronide in Bone.

Authors:  Andrew G Kunihiro; Paula B Luis; Julia A Brickey; Jen B Frye; H-H Sherry Chow; Claus Schneider; Janet L Funk
Journal:  J Nat Prod       Date:  2019-02-22       Impact factor: 4.050

Review 9.  Involvement of heparanase in atherosclerosis and other vessel wall pathologies.

Authors:  Israel Vlodavsky; Miry Blich; Jin-Ping Li; Ralph D Sanderson; Neta Ilan
Journal:  Matrix Biol       Date:  2013-03-13       Impact factor: 11.583

10.  Targeting of heparanase-modified syndecan-1 by prosecretory mitogen lacritin requires conserved core GAGAL plus heparan and chondroitin sulfate as a novel hybrid binding site that enhances selectivity.

Authors:  Yinghui Zhang; Ningning Wang; Ronald W Raab; Robert L McKown; Jacob A Irwin; Inchan Kwon; Toin H van Kuppevelt; Gordon W Laurie
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.